T2 Biosystems Announces Granting of CE-Mark for T2Resistance(TM) Panel

Stock Information for T2 Biosystems Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About T2 Biosystems Inc.

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.